Nouscom
Healthcare & Life Sciences
Recent Finacing
Series C
Recent Raise
$72.5M
Nouscom is a clinical-stage immuno-oncology company specializing in off-the-shelf and personalized cancer immunotherapies using a proprietary viral vector platform.
Focus Areas
Clinical-stage immuno-oncology
Cancer immunotherapies
Viral vector platform
Clinical pipeline advancement
Personalized immunotherapies
Off-the-shelf immunotherapies
Investors
